260 related articles for article (PubMed ID: 32354336)
1. Increased mortality of acute respiratory distress syndrome was associated with high levels of plasma phenylalanine.
Xu J; Pan T; Qi X; Tan R; Wang X; Liu Z; Tao Z; Qu H; Zhang Y; Chen H; Wang Y; Zhang J; Wang J; Liu J
Respir Res; 2020 Apr; 21(1):99. PubMed ID: 32354336
[TBL] [Abstract][Full Text] [Related]
2. Explore potential plasma biomarkers of acute respiratory distress syndrome (ARDS) using GC-MS metabolomics analysis.
Lin S; Yue X; Wu H; Han TL; Zhu J; Wang C; Lei M; Zhang M; Liu Q; Xu F
Clin Biochem; 2019 Apr; 66():49-56. PubMed ID: 30779905
[TBL] [Abstract][Full Text] [Related]
3. Associations of the plasma lipidome with mortality in the acute respiratory distress syndrome: a longitudinal cohort study.
Maile MD; Standiford TJ; Engoren MC; Stringer KA; Jewell ES; Rajendiran TM; Soni T; Burant CF
Respir Res; 2018 Apr; 19(1):60. PubMed ID: 29636049
[TBL] [Abstract][Full Text] [Related]
4. Circulating fibrocytes traffic to the lung in murine acute lung injury and predict outcomes in human acute respiratory distress syndrome: a pilot study.
Lin CM; Alrbiaan A; Odackal J; Zhang Z; Scindia Y; Sung SJ; Burdick MD; Mehrad B
Mol Med; 2020 May; 26(1):52. PubMed ID: 32460694
[TBL] [Abstract][Full Text] [Related]
5. Circulating angiopoietin 2 correlates with mortality in a surgical population with acute lung injury/adult respiratory distress syndrome.
Gallagher DC; Parikh SM; Balonov K; Miller A; Gautam S; Talmor D; Sukhatme VP
Shock; 2008 Jun; 29(6):656-61. PubMed ID: 18091573
[TBL] [Abstract][Full Text] [Related]
6. Serum metabolomic signatures of fatty acid oxidation defects differentiate host-response subphenotypes of acute respiratory distress syndrome.
Suber TL; Wendell SG; Mullett SJ; Zuchelkowski B; Bain W; Kitsios GD; McVerry BJ; Ray P; Ray A; Mallampalli RK; Zhang Y; Shah F; Nouraie SM; Lee JS
Respir Res; 2023 May; 24(1):136. PubMed ID: 37210531
[TBL] [Abstract][Full Text] [Related]
7. Distinct Metabolic Endotype Mirroring Acute Respiratory Distress Syndrome (ARDS) Subphenotype and its Heterogeneous Biology.
Viswan A; Ghosh P; Gupta D; Azim A; Sinha N
Sci Rep; 2019 Feb; 9(1):2108. PubMed ID: 30765824
[TBL] [Abstract][Full Text] [Related]
8. Δ9-Tetrahydrocannabinol Prevents Mortality from Acute Respiratory Distress Syndrome through the Induction of Apoptosis in Immune Cells, Leading to Cytokine Storm Suppression.
Mohammed A; F K Alghetaa H; Miranda K; Wilson K; P Singh N; Cai G; Putluri N; Nagarkatti P; Nagarkatti M
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32872332
[TBL] [Abstract][Full Text] [Related]
9. Decreased microRNA 103 and microRNA 107 predict increased risks of acute respiratory distress syndrome and 28-day mortality in sepsis patients.
Wang Q; Feng Q; Zhang Y; Zhou S; Chen H
Medicine (Baltimore); 2020 Jun; 99(25):e20729. PubMed ID: 32569211
[TBL] [Abstract][Full Text] [Related]
10. Circulating angiopoietin-2 and the risk of mortality in patients with acute respiratory distress syndrome: a systematic review and meta-analysis of 10 prospective cohort studies.
Li F; Yin R; Guo Q
Ther Adv Respir Dis; 2020; 14():1753466620905274. PubMed ID: 32043429
[TBL] [Abstract][Full Text] [Related]
11. Unique patterns of lower respiratory tract microbiota are associated with inflammation and hospital mortality in acute respiratory distress syndrome.
Kyo M; Nishioka K; Nakaya T; Kida Y; Tanabe Y; Ohshimo S; Shime N
Respir Res; 2019 Nov; 20(1):246. PubMed ID: 31694652
[TBL] [Abstract][Full Text] [Related]
12. Proteomic profiles in acute respiratory distress syndrome differentiates survivors from non-survivors.
Bhargava M; Becker TL; Viken KJ; Jagtap PD; Dey S; Steinbach MS; Wu B; Kumar V; Bitterman PB; Ingbar DH; Wendt CH
PLoS One; 2014; 9(10):e109713. PubMed ID: 25290099
[TBL] [Abstract][Full Text] [Related]
13. The Predictive Value of Plasma Galectin-3 for Ards Severity and Clinical Outcome.
Xu Z; Li X; Huang Y; Mao P; Wu S; Yang B; Yang Y; Chen K; Liu X; Li Y
Shock; 2017 Mar; 47(3):331-336. PubMed ID: 27648691
[TBL] [Abstract][Full Text] [Related]
14. IGF1 and IGFBP3 in acute respiratory distress syndrome.
Ahasic AM; Zhai R; Su L; Zhao Y; Aronis KN; Thompson BT; Mantzoros CS; Christiani DC
Eur J Endocrinol; 2012 Jan; 166(1):121-9. PubMed ID: 22004906
[TBL] [Abstract][Full Text] [Related]
15. ARDS metabolic fingerprints: characterization, benchmarking, and potential mechanistic interpretation.
Metwaly S; Côté A; Donnelly SJ; Banoei MM; Lee CH; Andonegui G; Yipp BG; Vogel HJ; Fiehn O; Winston BW
Am J Physiol Lung Cell Mol Physiol; 2021 Jul; 321(1):L79-L90. PubMed ID: 33949201
[TBL] [Abstract][Full Text] [Related]
16. Increased plasma levels of heparin-binding protein in patients with acute respiratory distress syndrome.
Lin Q; Shen J; Shen L; Zhang Z; Fu F
Crit Care; 2013 Jul; 17(4):R155. PubMed ID: 23883488
[TBL] [Abstract][Full Text] [Related]
17. Plasma soluble thrombomodulin levels are associated with mortality in the acute respiratory distress syndrome.
Sapru A; Calfee CS; Liu KD; Kangelaris K; Hansen H; Pawlikowska L; Ware LB; Alkhouli MF; Abbott J; Matthay MA;
Intensive Care Med; 2015 Mar; 41(3):470-8. PubMed ID: 25643902
[TBL] [Abstract][Full Text] [Related]
18. A systematic review of biomarkers multivariately associated with acute respiratory distress syndrome development and mortality.
van der Zee P; Rietdijk W; Somhorst P; Endeman H; Gommers D
Crit Care; 2020 May; 24(1):243. PubMed ID: 32448370
[TBL] [Abstract][Full Text] [Related]
19. Development of a biomarker mortality risk model in acute respiratory distress syndrome.
Bime C; Casanova N; Oita RC; Ndukum J; Lynn H; Camp SM; Lussier Y; Abraham I; Carter D; Miller EJ; Mekontso-Dessap A; Downs CA; Garcia JGN
Crit Care; 2019 Dec; 23(1):410. PubMed ID: 31842964
[TBL] [Abstract][Full Text] [Related]
20. Plasma Adiponectin, clinical factors, and patient outcomes during the acute respiratory distress syndrome.
Walkey AJ; Demissie S; Shah D; Romero F; Puklin L; Summer RS
PLoS One; 2014; 9(9):e108561. PubMed ID: 25259893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
